Literature DB >> 18463814

Utility of the ovariectomized rat as a model for human osteoporosis in drug discovery.

Yogendra P Kharode1, Michael C Sharp, Peter V N Bodine.   

Abstract

Ovariectomy-induced osteopenia in the rat produces skeletal responses similar to that in a post-menopausal woman. In the ovariectomized (ovx) rat, high bone turnover, and subsequent bone loss, like in the human post-menopausal condition, can be prevented by estrogen replacement. Because of the striking resemblance of skeletal responses in humans and rats in the state of estrogen deficiency, the ovx rat is considered to be a gold standard model for evaluating drugs for prevention and reversal of osteoporosis. This chapter describes the procedure for performing ovariectomy on the rat and the utility of the ovx rat model we have utilized over the last two decades in our laboratory.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463814     DOI: 10.1007/978-1-59745-104-8_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  20 in total

1.  Improvement of intertrochanteric bone quality in osteoporotic female rats after injection of polylactic acid-polyglycolic acid copolymer/collagen type I microspheres combined with bone mesenchymal stem cells.

Authors:  Zhengrong Yu; Tianyue Zhu; Chunde Li; Xudong Shi; Xianyi Liu; Xin Yang; Haolin Sun
Journal:  Int Orthop       Date:  2012-04-27       Impact factor: 3.075

2.  Effects of diabetes mellitus on the rat liver during the postmenopausal period.

Authors:  Deniz Unal; Selina Aksak; Zekai Halici; Ozlem Sengul; Beyzagul Polat; Bunyami Unal; Mesut Halici
Journal:  J Mol Histol       Date:  2011-05-21       Impact factor: 2.611

Review 3.  Nonproliferative and Proliferative Lesions of the Rat and Mouse Skeletal Tissues (Bones, Joints, and Teeth).

Authors:  Stacey Fossey; John Vahle; Philip Long; Scott Schelling; Heinrich Ernst; Rogely Waite Boyce; Jacquelin Jolette; Brad Bolon; Alison Bendele; Matthias Rinke; Laura Healy; Wanda High; Daniel Robert Roth; Michael Boyle; Joel Leininger
Journal:  J Toxicol Pathol       Date:  2016-07-29       Impact factor: 1.628

4.  Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats.

Authors:  Mostafa Shahrezaee; Ahmad Oryan; Farshid Bastami; Sepanta Hosseinpour; Mohammad Hossein Shahrezaee; Amir Kamali
Journal:  Endocrine       Date:  2018-01-25       Impact factor: 3.633

5.  L-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats.

Authors:  Hussam A S Murad
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

6.  Calcitonin alleviates hyperalgesia in osteoporotic rats by modulating serotonin transporter activity.

Authors:  C-B Yeh; S-J Weng; K-W Chang; J Y-H Chan; S-M Huang; T-H Chu; N-K Wei; H-S Ma; J-T Cheng; K-H Ma; T-H Chen; J-F Shyu
Journal:  Osteoporos Int       Date:  2016-06-03       Impact factor: 4.507

Review 7.  Morphological and molecular characterization of the senile osteoporosis in senescence-accelerated mouse prone 6 (SAMP6).

Authors:  Kagaku Azuma; Qian Zhou; Kin-Ya Kubo
Journal:  Med Mol Morphol       Date:  2018-04-04       Impact factor: 2.309

8.  Establishing a rapid animal model of osteoporosis with ovariectomy plus low calcium diet in rats.

Authors:  Xiang Gao; Wentao Ma; Huajing Dong; Zheng Yong; Ruibin Su
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

9.  YC-1 alleviates bone loss in ovariectomized rats by inhibiting bone resorption and inducing extrinsic apoptosis in osteoclasts.

Authors:  Jin-Wen Wang; Chin-Bin Yeh; Shao-Jiun Chou; Kuo-Cheng Lu; Tzu-Hui Chu; Wei-Yu Chen; Jui-Lin Chien; Mao-Hsiung Yen; Tien-Hua Chen; Jia-Fwu Shyu
Journal:  J Bone Miner Metab       Date:  2017-10-05       Impact factor: 2.626

10.  Estrogen/estrogen receptor alpha signaling in mouse posterofrontal cranial suture fusion.

Authors:  Aaron W James; Alexander A Theologis; Samantha A Brugmann; Yue Xu; Antoine L Carre; Philipp Leucht; Katherine Hamilton; Kenneth S Korach; Michael T Longaker
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.